Autologous hematopoietic cell transplantation following high-dose immunosuppressive therapy for advanced multiple sclerosis: long-term results.
about
The role of stem cell therapy in multiple sclerosis: An overview of the current status of the clinical studiesEvaluation of Study and Patient Characteristics of Clinical Studies in Primary Progressive Multiple Sclerosis: A Systematic ReviewIntrathecal IgG synthesis: a resistant and valuable target for future multiple sclerosis treatmentsHematopoietic stem cell transplantation for multiple sclerosis: is it a clinical reality?Autologous hematopoietic stem cell transplantation in multiple sclerosis: 20 years of experience.Hematopoietic stem cell therapy for multiple sclerosis: top 10 lessons learned.A comprehensive and quantitative analysis of the major specificities in rabbit antithymocyte globulin preparations.The development of hematopoietic and mesenchymal stem cell transplantation as an effective treatment for multiple sclerosis.High-dose immunosuppressive therapy and autologous HCT for relapsing-remitting MS.Disease-modifying treatments for progressive multiple sclerosis.Autologous bone marrow transplantation for the treatment of multiple sclerosis.Current role of chemotherapy and bone marrow transplantation in multiple sclerosis.Long-term Outcomes After Autologous Hematopoietic Stem Cell Transplantation for Multiple Sclerosis.An update on the use of cerebrospinal fluid analysis as a diagnostic tool in multiple sclerosis.Cell Therapy for Multiple Sclerosis.Autologous haematopoietic stem cell transplantation for treatment of multiple sclerosis.Effects of natalizumab on oligoclonal bands in the cerebrospinal fluid of multiple sclerosis patients: a longitudinal study.Long-term follow-up more than 10 years after HSCT: a monocentric experience.Long-term outcomes of autologous hematopoietic stem cell transplantation with reduced-intensity conditioning in multiple sclerosis: physician's and patient's perspectives.Defective expression of apoptosis-related molecules in multiple sclerosis patients is normalized early after autologous haematopoietic stem cell transplantation.
P2860
Q26750597-40FDF13A-2283-4F1E-B8C0-51FECBF0C83EQ26782408-691F9C6A-F8B7-4B45-AA22-5D47877B5D0FQ26851694-A77D93E1-F888-4367-BA4B-1D9F4E508576Q28071992-85415B55-1AF6-4631-8870-95AB68535E6DQ31075436-1EA56D1D-2D21-4FCD-8A31-895A1FF8400BQ34314312-2E6C36C4-5019-4E0C-A589-920FD37D6299Q35028105-2F2168BC-A20E-4ADD-9308-4244E31E11D3Q37003127-14480921-066D-4798-A69B-17259CE6BEB7Q37673801-F635837C-CE59-4AD3-9213-E3DD43F03508Q38142030-C58A9AE8-DE9F-4CB0-BFE6-F2E7F86D7114Q38231123-0CBC521A-5040-40DD-ACFC-28867C150C3BQ38268313-F742419D-9971-4286-9913-E87759249375Q38939585-38829ECA-8519-48A2-818D-CF7E1E012F05Q39027028-83107849-5E9F-4A48-BD98-AC331AD18663Q39233323-B6B8514B-5E5C-47DA-ABBC-340F3C42FB5AQ39378263-BC629C40-F60E-4A62-A4B0-674824888676Q44869530-2C7E0806-3D3C-46C2-9BAF-72C2D8C4CAF8Q47261875-286E5491-CAAB-4844-8F41-442E04965323Q48048274-C9F5E177-9432-4879-A540-0A8DB65685ADQ51240973-707C9699-80AA-4FD8-BA5B-92CE52D6F6A9
P2860
Autologous hematopoietic cell transplantation following high-dose immunosuppressive therapy for advanced multiple sclerosis: long-term results.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Autologous hematopoietic cell ...... sclerosis: long-term results.
@ast
Autologous hematopoietic cell ...... sclerosis: long-term results.
@en
type
label
Autologous hematopoietic cell ...... sclerosis: long-term results.
@ast
Autologous hematopoietic cell ...... sclerosis: long-term results.
@en
prefLabel
Autologous hematopoietic cell ...... sclerosis: long-term results.
@ast
Autologous hematopoietic cell ...... sclerosis: long-term results.
@en
P2093
P2860
P356
P1476
Autologous hematopoietic cell ...... sclerosis: long-term results.
@en
P2093
B A McLaughlin
G R Henstorf
H Openshaw
K R Maravilla
P A McSweeney
P2860
P2888
P304
P356
10.1038/BMT.2011.208
P407
P577
2011-11-07T00:00:00Z